Product: Cubicin (daptomycin for injection), 500 mg per vial, Single-dose vial, Rx only. Manuf. for: Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Whitehouse Station, NJ 08889, USA. Manuf. by: Baxter Pharmaceuticals LLC., Bloomington, IN 47403, USA, NDC: 67919-011-01
Reason for recall: Presence of Particulate Matter: Identified as Glass Particles
Recall initiated: 20211019
Status: Terminated
Classification: Class I
Recall type: Voluntary: Firm initiated